BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li HQ, Liu N, Zheng ZY, Teng HL, Pei J. Clopidogrel delays and can reverse diabetic nephropathy pathogenesis in type 2 diabetic db/db mice. World J Diabetes 2022; 13(8): 600-612 [PMID: 36159226 DOI: 10.4239/wjd.v13.i8.600]
URL: https://www.wjgnet.com/1948-9358/full/v13/i8/600.htm
Number Citing Articles
1
Christoph A. Gebeshuber, Lisa Daniel-Fischer, Heinz Regele, Helga Schachner, Christoph Aufricht, Christoph Kornauth, Matthias Ley, Seth L. Alper, Rebecca Herzog, Klaus Kratochwill, Paul Perco. Computational drug repositioning of clopidogrel as a novel therapeutic option for focal segmental glomerulosclerosisTranslational Research 2023; 259: 28 doi: 10.1016/j.trsl.2023.04.001
2
Limin Qin, Qian Li, Liqiang Wang, Yifei Huang. Mass cytometry reveals the corneal immune cell changes at single cell level in diabetic miceFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1253188
3
Bing Li, Yaoting Zhang, Yang Zheng, He Cai. The mechanisms and therapeutic potential of clopidogrel in mitigating diabetic cardiomyopathy in db/db miceiScience 2024; 27(3): 109134 doi: 10.1016/j.isci.2024.109134